Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03379363 · ClinicalTrials.gov registry record
Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome
A clinical trial, sponsored by Corcept Therapeutics.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03379363 is a clinical trial that was terminated before completion, run by Corcept Therapeutics. The registered enrollment target is 2 participants.
The verdict
NCT03379363 was terminated before completion, sponsored by Corcept Therapeutics.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This retrospective, multi-center, chart review study will collect patient data from medical charts of pediatric patients who have been treated with Korlym for Cushing's syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2018-02-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03379363
The ClinicalTrials.gov registry entry for NCT03379363 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corcept Therapeutics, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03379363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03379363 about?
NCT03379363 is a clinical study titled "Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome". This retrospective, multi-center, chart review study will collect patient data from medical charts of pediatric patients who have been treated with Korlym for Cushing's syndrome.
What is the current status of trial NCT03379363?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2017-09-18. Estimated completion is 2018-02-12.
Who is sponsoring clinical trial NCT03379363?
This trial is sponsored by Corcept Therapeutics, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.